Sief_Twist Sign a Novel View in Fetal Echocardiography
1 other identifier
observational
600
1 country
1
Brief Summary
To describe Sief\_twist sign as a novel sign in fetal echocardiography as a new ,easy , time effective view in fetal heart examination .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
October 15, 2020
CompletedFirst Posted
Study publicly available on registry
October 22, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 4, 2024
CompletedFebruary 20, 2024
February 1, 2024
3.8 years
October 15, 2020
February 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
obtaining clear images for fetal cardiac structures via standard views which is 4 chamber view[4CH.], left outflow tract view[LVOT.] , right outflow tract view [RVOT.], three vesseles trachea view [3VTV.]
4 chamber view that describe 4 heart chambers which are 2 atria , 2 ventricles - LVOT. view describes outflow of aorta from left ventricle in normal heart - RVOT describe outflow of pulmonary from rt. ventricle in normal heart - 3VTV describes view of aorta, pulonary and superior viena cava at upper chest
15 miutes
Study Arms (3)
A
Extended fetal heart examination
B
Modified extended heart examination
C
Sief\_Twist sign only examination
Interventions
Eligibility Criteria
observational study conducted at academic perinatal center that investigates Sief\_Twest sign as novel sign in fetal heart examination in comparison with classic standard views Patients who give written consent to participate in the study undergo a uniform antenatal assessment protocol that includes basic obstetrics ultrasound examination , fetal anatomy scan \& fetal echocardiography .
You may qualify if:
- Singleton fetus .
- gestational age 14-37 weeks.
- no maternal medical disorder .
- no morbed obisity.
You may not qualify if:
- evidence of fetal infection.
- chorioamnionitis.
- fetal anomalies.
- abnormal fetal karyotype
- patient withdrawal from the study and/or unavailability for follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut university
Asyut, Egypt
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 15, 2020
First Posted
October 22, 2020
Study Start
January 1, 2020
Primary Completion
October 1, 2023
Study Completion
February 4, 2024
Last Updated
February 20, 2024
Record last verified: 2024-02